Procept Biorobotics Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.9% | -5.4% | -2.2% | -0.1% | +42.7% | -2.7% | -1.2% | -0.3% | -0.7% | -4.1% | -1.6% | |
| – | -4.9% | -6.1% | -2.2% | +0.3% | +49.2% | -3.4% | -1.7% | -0.8% | -0.8% | -5.0% | -1.8% | |
| – | -10.6% | -12.3% | -5.1% | -8.1% | +69.6% | -5.2% | -4.3% | -2.8% | -2.6% | -14.3% | -7.2% | |
| – | -10.6% | -12.3% | -5.1% | -8.1% | +69.6% | -5.2% | -4.3% | -2.8% | -2.6% | -14.3% | -7.2% | |
| – | +39.7% | +15.9% | +5.1% | +17.2% | +20.9% | -5.1% | +2.0% | +4.6% | -1.1% | +15.4% | +11.6% | |
| – | -5.8% | +4.7% | +5.4% | +15.9% | +10.5% | +11.0% | +7.5% | -0.5% | +6.0% | +9.7% | -0.6% | |
| – | -5.4% | -5.6% | -6.0% | -6.4% | -6.8% | -7.3% | -8.0% | -8.6% | -2.5% | -9.7% | -10.8% | |
| – | +1.8% | -4.1% | +3.1% | +8.4% | -0.8% | -1.2% | -2.3% | +3.1% | +8.3% | -2.0% | -0.1% | |
| – | +11.1% | -15.8% | +10.9% | +25.2% | -1.0% | -2.0% | -4.5% | +8.4% | +22.1% | -3.3% | +0.9% | |
| – | -1.1% | +1.1% | +4.0% | +4.0% | +3.9% | +3.8% | +3.8% | +3.7% | +3.7% | +6.5% | +6.2% | |
| – | -0.7% | -25.3% | -1.3% | +51.6% | -33.5% | +47.8% | -20.5% | -5.6% | +55.5% | +9.1% | -20.1% | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | |
| – | -6.2% | -6.0% | -4.6% | -4.2% | +66.7% | -3.2% | -0.9% | -1.4% | -3.8% | -5.0% | -2.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.7% | +0.8% | +1.2% | +0.8% | +3.5% | +2.0% | +1.0% | +0.5% | +0.6% | +0.8% | +0.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.